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Insomnia is the most common, and often
frustrating, sleep-related complaint doc-
tors have to deal with. Up to one-third of
the population suffers from a sleep disor-
der at some time in their life. Insomnia
can be a primary problem, or it can be
secondary to medical or psychiatric disor-
ders or to medications and drugs of
abuse. Insomnia can also be caused by
psychophysiological factors such as jet lag.
Sedative-hypnotic drugs are often pre-
scribed for the treatment of insomnia. It
is, however, necessary to understand the
differential diagnosis of insomnia before
treating it symptomatically as sympto-
matic treatment often removes the impe-
tus to diagnose and relieve underlying
causes. Treating the primary condition
often relieves the insomnia, and sympto-
matic treatment can be avoided. It is
therefore important to make an appropri-
ate diagnosis and ask a few screening
questions to all patients complaining of
insomnia, poor quality of sleep or exces-
sive daytime sleepiness. Screening ques-
tions in combination with a physical work-
up and sleep laboratory studies, when
indicated, should enable the clinician to
refine the diagnosis to a specific sleep dis-
order and to plan an appropriate manage-
ment strategy. Treatment options include
behaviour changes, addressing underlying




According to the Diagnostic and Statistical
Manual of Mental Disorders IV (DSM IV),
insomnia is associated with complaints
about the quantity, quality or timing of
sleep. Insomnia should be present at least
3 times a week over a period of at least
one month. Patients can complain either
of difficulty in initiating or maintaining
sleep, or of non-restorative sleep.
Physicians often judge sleep according to
duration alone, while ignoring the sleep
quality.
CLASSIFICATION AND DIFFER-
ENTIAL DIAGNOSIS OF SLEEP
DISORDERS
DSM IV classifies sleep disorders into
three categories:
• primary sleep disorders
• sleep disorders related to other mental
disorders
• sleep disorders related to general med-
ical conditions or substances.
Primary sleep disorders are presumed to
arise from endogenous abnormalities in
sleep-wake generating or timing mecha-
nisms, often complicated by factors of
conditioning.
The International Classification of Sleep
Disorders (ICSD) (Table I) is, however,
the most advanced nosology available.The
dyssomnias are disorders of sleep and
wakefulness, whereby sufferers have diffi-
culty in initiating or maintaining sleep, or
may sleep excessively. The parasomnias
are disorders of transition from one sleep
stage to another, arousal, or partial
arousal. General medical psychiatric dis-
orders are not primarily disorders of
sleep, but are frequently associated with
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Physicians often judge
sleep according to 
duration alone, while
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it. Medical-psychiatric disorders
and drugs associated with sleep
problems are summarised in Table
II. Parasomnias are mentioned
only briefly as these patients do
not normally present with com-




These disorders originate within or
are caused by some conditions  in
the body. However, they exclude
general mental and medical condi-
tions such as major depression,
chronic pain and gastro-
oesophageal reflux which are clas-
sified under a separate heading in
the ICSD. Drug-related sleep dis-
orders are classified under dyssom-
nias as extrinsic sleep disorders.
Psychophysiological insomnia 
Psychophysiological insomnia is
the most common sleep disorder,
and the sleep disorder in the ICSD
that most closely resembles the
DSM III category of primary
insomnia. The onset is usually
associated with tension and fre-
quently follows an adjustment
sleep disorder precipitated by stres-
sors (see ‘Adjustment sleep disor-
der’ below). The patient complains
of difficulty in initiating and main-
taining sleep or of non-restorative
sleep for at least one month.
Dyssomnias
Intrinsic sleep disorders (excludes general medical and mental 
disorders)
Extrinsic sleep disorders (includes medication/drug-related causes,
poor sleep hygiene, emotional, and stress-related causes) 




Parasomnias usually associated with REM sleep 
Sleep disorders associated with medical-psychiatric disorders
(Table II)
Associated with mental disorders
Associated with neurological disorders
Associated with other medical disorders
Adapted from Kaplan HI, Sadock BJ. Comprehensive Textbook of Psychiatry.  6th ed. Baltimore, Md:  Williams &
Wilkins, 1996.
Table I. The International Classification of Sleep
Disorders (ICSD)
General medical disorders Psychiatric disorders Medication and substances of 
abuse
Cardiopulmonary Adjustment disorders Alcohol
Coronary or pulmonary (stress related) Use or withdrawal
insufficiency Post-traumatic stress disorder Sedative-hypnotic     
Congestive heart failure Generalised anxiety disorder Tolerance or withdrawal
Chronic obstructive pulmonary Panic disorder Stimulants   
disease Major depression Stimulating antidepressants — 
Asthma Bipolar mood disorder SSRIs
Nocturnal cardiac ischaemia Phobias Theophylline    
Sleep apnoea* Psychosis Caffeine
Pain related Nicotine
Chronic pain Cocaine
Fibromyositis Other      




Parkinson's disease Oral contraceptives
Hyperthyroidism Steroids      
Other Toxins (mercury, bismuth, lead)
Gastro-oesophageal reflux disease
Peptic ulcer disease
*See ‘Intrinsic sleep disorders’.
SSRIs — selective serotonin reuptake inhibitors.
Table II. Medical and psychiatric causes of insomnia
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Increased physiological or psycho-
logical arousal during the night
and negative conditioning for sleep
are frequently evident. Decreased
functioning during wakefulness is
also present. These patients expe-
rience a sense of frustration con-
cerning their inability to sleep. The
harder they try to sleep the more
difficult it becomes.
Behaviour treatment modalities
include moving to another bed,
using the bed for sleep and sexual
activity only, and relaxation train-
ing. These behaviour modalities
are the first line of treatment, but
can be combined with a hypnotic
agent if necessary.
Sleep state misperception 
Sleep state misperception is a dis-
order in which the patient com-
plains of insomnia without objec-
tive evidence (sleep studies or
observation) of sleep disturbance.
These patients are overly con-
cerned about the effects of dimin-
ished sleep. Reassurance and
attempts to identify underlying
psychological concerns are fre-
quently unsuccessful. Hypnotic
use should be limited as the risk
for dependence may be high.
Restless legs syndrome
Restless legs syndrome (RLS) is
experienced as a discomfort in the
legs which is relieved by moving or
stimulating the legs. This feeling is
commonly described as a crawling,
tingling or prickling sensation. The
symptoms tend to increase later in
the day or evening. Patients report
difficulty in falling asleep as they
have to keep on moving their legs
to relieve the uneasy sensations.
Getting up and walking around,
taking a hot shower or rubbing the
legs may provide some relief .
Pharmacotherapy needs to be
explored and individualised
because of differing responses.
Various drugs such as dopaminer-
gic agents (carbidopa/levodopa),
dopamine agonists, opioids, benzo-
diazepines (especially clonazepam)
and gabapentin have been shown
to improve symptoms. This condi-
tion and periodic limb movement
disorder are more common in
older patients. Iron supplements
have proved to be effective in
patients with serum ferritin levels
below 50 µg/dl. Pregnant women
or patients on antidepressants
complaining of insomnia should
also be asked about restless legs.
SSRIs have also been associated
with RLS.
Periodic limb movement disor-
der (nocturnal myoclonus)
This disorder is characterised by
periodic episodes of repetitive,
stereotyped limb movements that
occur during sleep. These patients
are unaware of the limb move-
ments and complain of either
interrupted sleep or excessive day-
time sleepiness. Bed partners
should be questioned about exces-
sive leg movements during sleep.
The diagnosis can also be con-
firmed by polysomnographic stud-
ies.
Idiopathic insomnia
Idiopathic insomnia is a lifelong
inability to obtain adequate sleep.
Some defect in the neurological
control of the sleep-wake system
probably explains the condition.
This condition is characterised by
lifelong sleep difficulties beginning
in childhood.
Narcolepsy
Narcolepsy is a neurological disor-
der of unknown aetiology charac-
terised by excessive daytime sleepi-
ness associated with cataplexy
(episodes of abrupt decrease in
muscle tone) and other REM sleep
phenomena such as sleep paralysis
(temporary inability to talk or
move while falling asleep or awak-
ening) and hypnagogic hallucina-
tions (occurring in the transition
from wakefulness to sleep or when
dozing). Only a minority of
patients experience all four of the
above symptoms. Cataleptic
attacks can consist of either brief,
almost imperceptible weakness of
isolated muscle groups (loss of
grip, jaw drop, head drop) or sud-
den paralysis of almost all skeletal
muscles. These attacks are fre-
quently triggered by intense emo-
tions or sexual arousal.
The onset of narcolepsy usually
occurs during the second decade
of life, with excessive daytime
sleepiness preceding the other
symptoms by several years.The
diagnosis is confirmed by
polysomnographic studies indicat-
ing the presence of sleep-onset
REM periods (decreased sleep
latency) and hypersomnolence dur-
ing daytime.
There is no cure for narcolepsy but
it can be managed with stimulant
medications such as dextroamphet-
amine and methylphenidate. Drug
holidays are recommended to min-
imise development of tolerance.
However, abuse potential of these
drugs remains a concern.
Modafinil is a newly registered
novel, wake-promoting agent for
the treatment of narcolepsy. It has
a mechanism of action similar to
that of sympathomimetics that dif-
fers from amphetamine and
amphetamine-like stimulants.
Idiopathic insomnia
is a lifelong inability
to obtain adequate
sleep.  Some defect
in the neurological
control of the sleep-
wake system proba -
bly explains the
c o n d i t i o n .
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Recently, low levels of hypocretin,
a newly identified neuropeptide,
were described in the cerebrospinal
fluid of patients with narcolepsy.
The role of hypocretins in nar-
colepsy is intriguing but unclear at
this stage.
Obstructive sleep apnoea syn-
drome
Obstructive sleep apnoea syn-
drome is characterised by repetitive
episodes of upper airway obstruc-
tion that occur during sleep. This
is usually associated with reduction
of blood oxygen saturation.
Obstructive apnoea results from a
collapse of the upper airways,
despite a continuous effort to
breathe. The obstruction is
released when the patient is briefly
aroused or wakes up completely.
Obstructive sleep apnoea is often
associated with overweight, middle-
aged men, but can occur at any age
and also in women.These patients
present with excessive daytime
sleepiness. Loud snoring, morning
headaches and poor sexual func-
tioning are often present. Other
important symptoms are prolonged
but unrefreshing naps, periods of
disorientation and automatic
behaviour. Up to 50% of patients
who have essential hypertension
have obstructive sleep apnoea.
The diagnosis is confirmed by
polysomnographic investigations
indicating cessation of both nasal
and oral airflow for longer than 10
seconds more than 30 times during
a seven-hour sleep period.
Symptoms of hypersomnia, poor
concentration, irritability and per-
sonality changes overlap to some
extent with major depression.
Prescribing a sedating antidepres-
sant can aggravate sleep apnoea
and increases the patient's risk of
complications. Sleep apnoea
therefore needs to be considered in
the differential diagnosis of depres-
sion. A timely diagnosis can save a
patient’s life as sleep apnoea is
associated with cardiovascular dis-
ease fatalities.
Continuous positive airway pres-
sure (CPAP) or bi-level positive
airway pressure (BiPAP) are used
to pneumatically maintain an open
airway during sleep. These meth-
ods are generally well accepted by
patients. In patients who have
identifiable anatomical abnormali-
ties, orthognatic surgery appears to
be an excellent treatment option.
Various drug therapy trials for
sleep apnoea are currently being
conducted.
Recurrent hypersomnia
This disorder is relatively rare but
is most common among male ado-
lescents. Periodic hypersomnia
and excessive eating are its major
features.
Idiopathic hypersomnia
The patient suffering from this
syndrome takes long unrefreshing
naps preceded by long periods of
drowsiness. It differs from nar-
colepsy in that daytime sleepiness
is more continuous.
Extrinsic sleep disorders
The causes of the disorders arise
outside the body and include a
wide variety of contributing fac-
tors, including drugs, environment
and stressors.
Insufficient sleep syndrome
Many patients limit sleep time
unintentionally to less than that
necessary for normal day-to-day
functioning, perhaps owing to a
lack of understanding of his/her
sleep requirement.
Inadequate sleep hygiene
This category entails bad or irregu-
lar sleep habits and sleep-incom-
patible behaviours. Insomnia
results from behaviours that
increase arousal. Poor sleep
hygiene is also responsible for
maintaining some of the other
sleep disorders discussed in this
article.
Adjustment sleep disorder
This commonly occurring condi-
tion is caused by emotional stres-
sors or change of environment,
which results in an anxiety-mediat-
ed insomnia. The condition is nor-
mally self-limiting and remits once
the stressors have been removed or
are adjusted to.
Sleep disorder related to med-
ication and substances of a buse
Stimulant-, alcohol- and hypnotic-
related sleep disorder needs to be
ruled out in patients complaining
of insomnia (Table II). Short-
term co-prescription of sedative-
hypnotics can alleviate insomnia
aggravated by stimulating antide-
pressants. Tolerance to or with-
drawal from sedative-hypnotics is
often associated with insomnia.
Abrupt withdrawal should be
avoided as it can lead to interrupt-
ed sleep.
Circadian rhythm sleep disor-
ders
Adults have an intrinsic body clock
which regulates a complex series of
rhythms, including sleep and wake-
fulness, fatigue and cognitive abili-
ty. This endogenous clock is also
influenced by alternation of light
and darkness.
Jet lag, shift-work sleep disorder,
delayed and advanced sleep phase
syndromes and some of the chron-




needs to be ruled
out in patients
complaining of
i n s o m n i a .
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poral discrepancy of the body clock
in relation to environmental
requirements.
Some individuals, especially the
elderly, suffer from advanced sleep
phase syndrome (excessive sleepi-
ness in the evening and undesired
early morning waking). Delayed
sleep phase syndrome is more
common in adolescents (sleep-
onset insomnia and difficulty wak-
ing in the morning).
PARASOMNIAS 
These can be marked by unusual
or bizarre behaviour. Sleepwalking,
sleep terrors, nightmares, sleep
bruxism and sudden death syn-
drome in infants are some exam-
ples of parasomnias.
MANAGEMENT
Insomnia should be addressed to
avoid functional impairment and
the possible increased risk of devel-
oping anxiety and depressive ill -
nesses. Management includes
obtaining a proper history from
patients experiencing difficulties
with sleep or staying awake (Table
III). Identifying behaviour that can
interfere with sleep (poor sleep
hygiene) needs special attention
(Table IV). Underlying psychiatric
conditions (Table II) need to be
ruled out. Information about
duration of the problem can also
lead the clinician towards an
appropriate diagnosis (Table V).
Medical and psychiatric condi-
tions, as well as intrinsic sleep dis-
orders, need to be ruled out in
long-term insomnia. Information
about excessive leg movements,
snoring and breathing problems
should be obtained from bed part-
ners. A physical examination and
appropriate laboratory investiga-
tions to rule out possible underly-
ing medical problems need to be
undertaken. Keeping of sleep logs
can provide valuable information.
These should record time of going
to bed, sleep duration and time of
waking up during the night and
final time of waking up. Daytime
naps should also be recorded.
Although subjective, the log sum-
marises the patient’s perception of




ment of eye movements, oxygen
saturation, limb movements, air-
flow and chest and abdominal
movement. These studies are indi-
cated in long-term insomnia with
an unidentified cause or in treat-
• Is there difficulty falling asleep or early morning awakening?
• For how long does the person sleep?  Is it adequate?
• Does the sleeping problem affect functioning during the day?
• Does the person sleep during the day?
• Does the person take excessive amounts of caffeine or other stimu-
lants? 
• Is there an associated medical condition?
• What medication does the person take?
• Is there an underlying psychiatric disorder?
• What psychological or social stresses are there?
From Wilson D.   Psychiatry and primary health care.  In: Baumann SE, ed. A Practical Guide for Health Care
Workers in Southern Africa.  Kenwyn: Juta, 1998.
Table III. Assessment of sleeping problem
• Keep regular sleeping hours
• Go to bed only when feeling sleepy 
• Avoid bright light before bedtime 
• Avoid stimulants for six hours before going to bed (caffeine) 
• Avoid nicotine, especially near bedtime 
• Use the bed for sleeping only
• Avoid exercise near bedtime 
• Don’t eat a heavy meal before bedtime or go to bed hungry
• Get out of bed when unable to fall asleep within 30 minutes  
• Avoid alcohol near bedtime 
• Block excessive noise with white noise 
Compiled from Lippman S, Mazour I, Shahab H. Insomnia: therapeutic approach. South  Med J 2001; 94: (suppl
1): 15 - 24.
Table IV. Sleep hygiene (behaviour and environmen-
tal factors that promote good sleep)
Transient insomnia — lasting a few days
• Jet lag
• Change in sleeping environment Treatment usually not needed
• Acute stress
Short-term insomnia
• Stress that doesn’t resolve within a few days, such as divorce,
bankruptcy  —  may require short-term symptomatic treatment 
Long-term insomnia
• Psychiatric disorder
• Associated drug use/abuse/withdrawal/associated medical disor-
der
• Intrinsic sleep disorders
Table V. Classification of insomnia in terms of dura-
tion and probable causes in each group
}
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ment-resistant cases. Multiple sleep
latency tests are also indicated in




The best results are usually
achieved by employing more than
one component in the manage-
ment plan.
Non-pharmacological measures 
These are quite effective and
should always be regarded as the
first line of management. Skills
obtained through these measures
may have long-term benefits for
the patient. Moderate intensity
exercise should be promoted and
has been reported to improve self-
rated sleep quality and sleep dura-
tion in elderly patients.
The main psychological therapies
that have been studied include
sleep hygiene training, relaxation
therapies, stimulus control therapy,
sleep restriction therapy and para-
doxical intention. The principle of
sleep hygiene is to promote condi-
tions and behaviour that enhance
effective sleep (Table IV).
Relaxation procedures have been
employed with varying success
rates. Procedures such as progres-
sive muscle relaxation are designed
to alleviate somatic and cognitive
arousal. Attention-focusing proce-
dures target cognitive arousal
through imagery training, medita-
tion, and thought-stopping.
Paradoxical intention addresses the
conditioned inability to sleep.
Pharmacological measures
Established medications for the
symptomatic treatment of insom-
nia include non-benzodiazepine
hypnotics, benzodiazepines and
sedating antidepressants or occa-
sional histaminic drugs. The non-
benzodiazepines are rapidly
becoming the first-line treatment
for insomnia. Short-term use of
the lowest effective dose should be
used to minimise side-effects,
rebound insomnia and tolerance.
Sleep experts suggest that sedative-
hypnotic drugs be used for a maxi-
mum of several weeks. Short-term
insomnia should be treated for no
more than three weeks, while long-
term insomnia should be treated
intermittently whenever possible.
Chronic treatment can be one
night in three for up to four
months at a time.
Advantages of the non-benzodi-
azepines include a lower risk of
rebound insomnia, dependence,
withdrawal symptoms and loss of
efficacy over time.
There are numerous antidepres-
sants with sedative-hypnotic prop-
erties (Table VI). They are advised
for managing insomnia in patients
with depression, a history of sub-
stance abuse or where the need for
extended treatment duration exists.
Tricyclic antidepressants are effec-
tive for inducing sleep and improv-
ing sleep continuity. Low-dose tra-
zodone can be combined with
sleep-disrupting psychotropic
drugs such as SSRIs.
Antihistamines are effective for
managing mild insomnia but next-
day sedation and anticholinergic
effects may be problematic.
Novel non-benzodiazepines Sedating antidepressants
Zolpidem                  Amitriptyline 
Zopiclone                  Mirtazapine
Trazodone                
Nefazodone                 
Benzodiazepines Antihistamines
Oxazepam            Hydroxyzine  
Temazepam                
Alprazolam                  
Lorazepam
Compiled from Lippman S, Mazour I, Shahab H.  Insomnia: therapeutic approach.  South Med J 2001; 94: 866 -
873.
Table VI. Drugs commonly prescribed for insomnia
IN A NUTSHELL
Sleep disorders can present with
insomnia, poor quality of sleep or
excessive daytime sleepiness.
One-third of the population suf -
fers from sleep disorders at some
time in their life.  
An attempt should be made to
diagnose and treat or relieve
underlying causes of insomnia.
Symptomatic treatment is warrant-
ed if underlying causes do not
respond to treatment sufficiently.
Symptomatic treatment should be
time limited and preferably given
intermittently.
Non-pharmacological measures
should be regarded as part of
first-line management.  Patients
with treatment-resistant and long-
term insomnia of unidentified
cause should be referred.
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